#NephMadness 2023: Ready to Rumble
Submit your picks! | NephMadness 2023 | #NephMadness | #OncoNephrology Ben Humphreys @HumphreysLab Dr. Humphreys is Chief of the Division of Nephrology and the Joseph [...]
onconephrology
Can Checkpoint Inhibitors Pave the Way for A Generation of Targeted Therapies for Autoimmune Diseases?
When I was a medical resident, a novel developmental therapy for the treatment of certain cancers was to medically shut off the blood supply and cause ischemia to the mass. [...]
Light Chain Proximal Tubulopathy – The Tip of the Iceberg?
In recent years, there has been increased recognition of the spectrum of kidney diseases associated with paraproteinemias. The fact that the pathogenetically related [...]
Hemaphagocytic Syndrome and the Kidney: Is There a Connection?
Hemophagocytic syndrome (HPS), also known as hemophagocytic lymphohistiocytosis (HLH), is one of those rare diseases that one sees at the bottom of differential diagnoses in [...]
#SCM16: Eculizumab for Chemo-Induced aHUS
Dr. Sylvester Ogbata (SO), from the University of Tennessee Health Science Center in Memphis, Tennessee, discusses his abstract for the National Kidney Foundation’s 2016 [...]
Renal Amyloidosis – What We Need to Consider, Practical Tips
The AJKD Atlas of Renal Pathology II has recently provided a succinct summary of the diagnosis of AL (light chain) amyloidosis, the most common type of renal amyloidosis, and [...]
Test Your Knowledge: Onco-Nephrology
The overlap of hematology, oncology, and nephrology has led to the creation of a field called Onconephrology. Cancer survivors are living longer and developing chronic kidney [...]
Thrombotic Microangiopathy in Cancer Patients
Thrombotic microangiopathy (TMA) describes a set of disorders that are characterized by microvascular thrombosis, microangiopathic hemolytic anemia, thrombocytopenia, and [...]
Glomerular Diseases and Complement Activation
A recent Core Curriculum by Noris and Remuzzi is on the timely topic of activation of the complement system in glomerular disease. This focuses on our evolving understanding [...]
Cancer Incidence Among US Medicare Hemodialysis Patients
In their recent study “Cancer Incidence Among US Medicare ESRD Patients Receiving Hemodialysis, 1996-2009” published in the May issue of AJKD, Butler et al [...]